About Bethany Howell
Articles by Bethany Howell
Patients As Partners in Research: Your Contribution MattersMar 24, 2026
Navigating Health Risks For Adults Who Had Childhood CancerMar 19, 2026
Conditioning Therapy Options: Fludarabine and Melphalan for Older Adults with AML and MDSMar 18, 2026
Exploring the Use of Triplet Therapy to Treat BPDCNMar 11, 2026
How Socioeconomic Status Affects Health Outcomes for People with AMLMar 06, 2026
Cardiotoxicity: How Cancer Treatments Affect Your HeartMar 06, 2026
Resources for People with MGUS and Smoldering Multiple MyelomaMar 05, 2026
March is Multiple Myeloma Awareness MonthFeb 27, 2026
How Highly Sensitive Genetic Testing Can Help Shape AML Treatment DecisionsFeb 20, 2026
Can Genetic Information Present at Diagnosis Can Predict Relapse and Shape CML Treatment Planning?Feb 20, 2026
Using Salvage Therapy in AML to Achieve Durable RemissionFeb 20, 2026
The Importance of Social and Financial Support for Parents of Children with ALLFeb 17, 2026
What Is A Menin Inhibitor? How a New Type of Medication Treats Acute Myeloid LeukemiaFeb 17, 2026
Join HealthTree for a Myeloma Roundtable Near YouFeb 09, 2026
How MRD Status Could Help Predict Outcomes for People with High-Risk ALLFeb 03, 2026
What Research Tells Us About Sex-Based Differences in AML OutcomesJan 29, 2026
Upcoming Virtual Support Group for Caregivers: Gather Community EventJan 21, 2026
Moving Toward A Deeper Understanding of the Characteristics of BPDCNJan 12, 2026
Venetoclax and Azacitidine for AML: Better Responses and Fewer ComplicationsDec 21, 2025
What is Differentiation Syndrome?Dec 16, 2025
Latest ALL Research Updates at ASH 2025: CART19, Venetoclax, and huCART19Dec 09, 2025
Federal Funding Drives Breakthroughs in Rare DiseasesNov 27, 2025
FMLA Explained: Protected Leave for CaregiversNov 24, 2025
Some Older Adults With Multiple Myeloma Have Better Outcomes When Treated With Dexamethasone-Sparing RegimenNov 20, 2025